导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.11% | 3071/4773 |
| 近一周 | -2.08% | 1184/5462 |
| 近一月 | -2.96% | 1484/5421 |
| 近一季 | -4.38% | 1614/5209 |
| 近半年 | -4.78% | 2617/4920 |
| 近一年 | -1.43% | 2874/4366 |
| 近两年 | 42.17% | 1781/2954 |
| 近三年 | 27.53% | 1161/2253 |
| 成立以来 | 426.26% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.26% 3581/4961 |
7.90% 2649/5312 |
- - |
- - |
| 2025 | 18.86% 2276/4813 |
-1.38% 2650/3635 |
2.95% 1241/4076 |
17.89% 2406/4524 |
-0.70% 2604/4813 |
| 2024 | 19.45% 524/3463 |
4.01% 489/2808 |
-0.40% 761/3014 |
16.38% 1471/3129 |
-0.93% 1547/3463 |
| 2023 | -7.38% 917/2656 |
3.33% 1216/2280 |
-3.46% 799/2385 |
-0.20% 406/2515 |
-6.98% 2001/2655 |
| 2022 | -16.76% 512/2207 |
-11.48% 517/1919 |
5.98% 798/2016 |
-12.83% 792/2113 |
1.79% 1140/2208 |
| 2021 | -3.35% 902/1822 |
-2.50% 656/1255 |
2.06% 1016/1330 |
-4.24% 693/1466 |
1.42% 939/1822 |
| 2020 | 22.53% 669/1250 |
-10.97% 811/1028 |
10.11% 776/1067 |
11.43% 449/1164 |
12.18% 494/1184 |
| 2019 | 32.54% 446/1092 |
24.80% 491/754 |
1.66% 115/804 |
-0.89% 621/850 |
5.40% 721/918 |
| 2018 | -19.87% 183/834 |
- - |
- - |
- - |
-11.56% 316/691 |
| 2017 | 21.56% 165/714 |
- - |
- - |
- - |
- - |
| 2016 | -7.87% 231/605 |
- - |
- - |
- - |
- - |
| 2015 | 1.43% 243/575 |
- - |
- - |
- - |
- - |
| 2014 | 62.71% 29/237 |
- - |
- - |
- - |
- - |
| 2013 | -7.22% 120/186 |
- - |
- - |
- - |
- - |
| 2012 | 12.43% 25/140 |
- - |
- - |
- - |
- - |
| 2011 | -22.58% 50/102 |
- - |
- - |
- - |
- - |
| 2010 | -15.45% 39/58 |
- - |
- - |
- - |
- - |
| 2009 | 87.71% 11/27 |
- - |
- - |
- - |
- - |
| 2008 | -64.55% 22/26 |
- - |
- - |
- - |
- - |
| 2007 | 146.39% 8/22 |
- - |
- - |
- - |
- - |
| 2006 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 华安上证180ETF VS. 长安沪深300非周期A(740101) |